Drug Shortage Report for ACH-PRAVASTATIN
| Report ID | 177042 |
| Drug Identification Number | 02440660 |
| Brand name | ACH-PRAVASTATIN |
| Common or Proper name | PRAVASTATIN SODIUM |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PRAVASTATIN SODIUM |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-12-02 |
| Estimated end date | 2023-08-07 |
| Actual end date | 2023-08-04 |
| Shortage status | Resolved |
| Updated date | 2023-08-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-12-02 | English | Compare |